DBV Technologies SA (DBVT)

0.6669 0.00 (0.00%) USD  |  NASDAQ  |  May 03, 16:00
0.662 0.00 (0.00%) Pre-Market: 20:00
More

DBV Technologies Total Liabilities (Quarterly): 42.80M for Dec. 31, 2023

Total Liabilities (Quarterly) Chart

Historical Total Liabilities (Quarterly) Data

View and export this data back to 2011. Upgrade now.
Date Value
December 31, 2023 42.80M
September 30, 2023 45.79M
June 30, 2023 53.28M
March 31, 2023 53.84M
December 31, 2022 52.06M
September 30, 2022 36.06M
June 30, 2022 40.56M
March 31, 2022 35.52M
December 31, 2021 47.45M
September 30, 2021 54.03M
June 30, 2021 57.56M
March 31, 2021 52.23M
December 31, 2020 66.76M
June 30, 2020 84.81M
December 31, 2019 78.54M
September 30, 2019 74.89M
June 30, 2019 79.97M
June 30, 2019 79.97M
December 31, 2018 57.72M
June 30, 2018 52.43M
Date Value
June 30, 2018 52.43M
December 31, 2017 57.45M
June 30, 2017 52.88M
June 30, 2017 52.88M
December 31, 2016 46.96M
June 30, 2016 41.79M
June 30, 2016 41.79M
December 31, 2015 23.18M
June 30, 2015 14.99M
June 30, 2015 14.99M
December 31, 2014 12.12M
June 30, 2014 9.888M
June 30, 2014 9.888M
December 31, 2013 8.066M
June 30, 2013 6.914M
June 30, 2013 6.914M
December 31, 2012 5.028M
June 30, 2012 3.300M
December 31, 2011 5.203M

Total Liabilities Definition

Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.

Read full definition.

Total Liabilities (Quarterly) Range, Past 5 Years

35.52M
Minimum
Mar 2022
84.81M
Maximum
Jun 2020
57.56M
Average
53.56M
Median

Total Liabilities (Quarterly) Benchmarks

Biophytis SA 17.52M
Edap TMS SA 38.27M
Cellectis SA 249.58M
Genfit SA 117.09M
Adaptimmune Therapeutics PLC 243.10M

Total Liabilities (Quarterly) Related Metrics

Total Assets (Quarterly) 182.99M
Shareholders Equity (Quarterly) 140.19M